Sank Leonard

Avg. Two Year Performance

13% Avg. Purchase Return
6% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return8%21%62%19%13%
Purchase Success Rate2 of 32 of 33 of 33 of 31 of 3
Average Sale Return----------
Sale Success Rate----------

Oramed Pharmaceuticals Inc.

Drugs » Biotechnology

Director:

Holdings: 98.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--